Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 24/05/20

Doi : 10.1016/j.resmer.2020.100769

N Girard ^a,⁎ , L Greillier ^b, G Zalcman ^c, J Cadranel ^d, D Moro-Sibilot ^e, J Mazières ^f, C Audigier-Valette ^g, J Bennouna ^h, B Besse ⁱ, A Cortot ^j, S Couraud ^k, M Duruisseaux ^k, E Giroux-Leprieur ^l, A C Toffart ^e, V Westeel ^m, M Wislez ⁿ
on behalf of the French-Language Society of Pulmonology (SPLF) / French-language Oncology Group
^a Department of Medical Oncology, Institut Curie, 75005, Paris, France
^b Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, 13915, Marseille, France
^c Department of Thoracic Oncology, CIC 1425, AP-HP, Hôpital Bichat Claude Bernard, 75018, Paris, France
^d Department of Thoracic Oncology, AP-HP, Hôpital Tenon, 75020, Paris, France
^e Department of Pneumology, University Hospital of Grenoble, 38043, Grenoble, France
^f Department of Pneumology, University Hospital of Toulouse, 31059, Toulouse, France
^g Department of Pneumology, Hôpital Sainte-Musse, 83100, Toulon, France
^h Department of Medical Oncology, University Hospital of Nantes, 44000, Nantes, France
ⁱ Department of Medical Oncology, Institut Gustave Roussy, 94800, Villejuif, France
^j Department of Pneumology, University Hospital of Lille, 59000, Lille, France
^k Department of Pneumology and Thoracic Oncology, University Hospital of Lyon, 69002, Lyon, France
^l Department of Thoracic Oncology, AP-HP, Hôpital Ambroise Paré, 92100, Boulogne-Billancourt, France
^m Department of Pneumology and Thoracic Oncology, University Hospital of Besançon, INSERM UMR 1098, Université de Franche-Comté, 25000, Besançon, France
ⁿ Department of Thoracic Oncology, AP-HP, Hôpital Cochin, Inserm UMR_S 1138, Université de Paris, 75014, Paris, France

^⁎Corresponding author at: Institut du Thorax Curie Montsouris, Institut Curie, 26 rue d’Ulm, 75005, Paris, FranceInstitut du Thorax Curie Montsouris, Institut Curie26 rue d’UlmParis75005France

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Manuscrit accepté. Disponible en ligne depuis le Sunday 24 May 2020
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF) / French-language oncology group. These proposals are evolving (10/04/2020) according to the situations encountered which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic. Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels.

Le texte complet de cet article est disponible en PDF.

Export

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 24/05/20

Abstract

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL